 |
PDBsum entry 4quh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
4quh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Caspase-3 t140g
|
|
Structure:
|
 |
Caspase-3. Chain: a, c. Synonym: casp-3, apopain, cysteine protease cpp32, cpp-32, protein yama, srebp cleavage activity 1, sca-1, caspase-3 subunit p17, caspase-3 subunit p12. Engineered: yes. Mutation: yes. Short peptde. Chain: d.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: casp3, cpp32. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Synthetic: yes
|
|
Resolution:
|
 |
|
1.76Å
|
R-factor:
|
0.155
|
R-free:
|
0.187
|
|
|
Authors:
|
 |
C.Cade,P.D.Swartz,S.H.Mackenzie,A.C.Clark
|
|
Key ref:
|
 |
C.Cade
et al.
(2014).
Modifying caspase-3 activity by altering allosteric networks.
Biochemistry,
53,
7582-7595.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Jul-14
|
Release date:
|
05-Nov-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P42574
(CASP3_HUMAN) -
Caspase-3 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
277 a.a.
233 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
53:7582-7595
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Modifying caspase-3 activity by altering allosteric networks.
|
|
C.Cade,
P.Swartz,
S.H.MacKenzie,
A.C.Clark.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Caspases have several allosteric sites that bind small molecules or peptides.
Allosteric regulators are known to affect caspase enzyme activity, in general,
by facilitating large conformational changes that convert the active enzyme to a
zymogen-like form in which the substrate-binding pocket is disordered. Mutations
in presumed allosteric networks also decrease activity, although large
structural changes are not observed. Mutation of the central V266 to histidine
in the dimer interface of caspase-3 inactivates the enzyme by introducing steric
clashes that may ultimately affect positioning of a helix on the protein
surface. The helix is thought to connect several residues in the active site to
the allosteric dimer interface. In contrast to the effects of small molecule
allosteric regulators, the substrate-binding pocket is intact in the mutant, yet
the enzyme is inactive. We have examined the putative allosteric network, in
particular the role of helix 3, by mutating several residues in the network. We
relieved steric clashes in the context of caspase-3(V266H), and we show that
activity is restored, particularly when the restorative mutation is close to
H266. We also mimicked the V266H mutant by introducing steric clashes elsewhere
in the allosteric network, generating several mutants with reduced activity.
Overall, the data show that the caspase-3 native ensemble includes the canonical
active state as well as an inactive conformation characterized by an intact
substrate-binding pocket, but with an altered helix 3. The enzyme activity
reflects the relative population of each species in the native ensemble.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |